|
Name |
Cryptosporiopsin A
|
Molecular Formula | C19H21ClO6 | |
IUPAC Name* |
(4R,10E)-15-chloro-16-hydroxy-18-methoxy-4-methyl-3-oxabicyclo[12.4.0]octadeca-1(18),10,14,16-tetraene-2,7,12-trione
|
|
SMILES |
C[C@@H]1CCC(=O)CC/C=C/C(=O)CC2=C(C(=CC(=C2C(=O)O1)OC)O)Cl
|
|
InChI |
InChI=1S/C19H21ClO6/c1-11-7-8-12(21)5-3-4-6-13(22)9-14-17(19(24)26-11)16(25-2)10-15(23)18(14)20/h4,6,10-11,23H,3,5,7-9H2,1-2H3/b6-4+/t11-/m1/s1
|
|
InChIKey |
WJNTWPSDKYZENI-DUMNWFOQSA-N
|
|
Synonyms |
Cryptosporiopsin A; 1402990-52-6; (4R,10E)-15-chloro-16-hydroxy-18-methoxy-4-methyl-3-oxabicyclo[12.4.0]octadeca-1(18),10,14,16-tetraene-2,7,12-trione; DTXSID201043651
|
|
CAS | 1402990-52-6 | |
PubChem CID | 71501071 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 380.8 | ALogp: | 2.8 |
HBD: | 1 | HBA: | 6 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 89.9 | Aromatic Rings: | 2 |
Heavy Atoms: | 26 | QED Weighted: | 0.736 |
Caco-2 Permeability: | -4.698 | MDCK Permeability: | 0.00002500 |
Pgp-inhibitor: | 0.043 | Pgp-substrate: | 0.005 |
Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.004 |
30% Bioavailability (F30%): | 0.005 |
Blood-Brain-Barrier Penetration (BBB): | 0.353 | Plasma Protein Binding (PPB): | 96.80% |
Volume Distribution (VD): | 0.606 | Fu: | 1.74% |
CYP1A2-inhibitor: | 0.848 | CYP1A2-substrate: | 0.905 |
CYP2C19-inhibitor: | 0.798 | CYP2C19-substrate: | 0.266 |
CYP2C9-inhibitor: | 0.771 | CYP2C9-substrate: | 0.956 |
CYP2D6-inhibitor: | 0.391 | CYP2D6-substrate: | 0.642 |
CYP3A4-inhibitor: | 0.685 | CYP3A4-substrate: | 0.219 |
Clearance (CL): | 11.873 | Half-life (T1/2): | 0.902 |
hERG Blockers: | 0.04 | Human Hepatotoxicity (H-HT): | 0.262 |
Drug-inuced Liver Injury (DILI): | 0.685 | AMES Toxicity: | 0.272 |
Rat Oral Acute Toxicity: | 0.136 | Maximum Recommended Daily Dose: | 0.926 |
Skin Sensitization: | 0.459 | Carcinogencity: | 0.767 |
Eye Corrosion: | 0.004 | Eye Irritation: | 0.04 |
Respiratory Toxicity: | 0.925 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC004730 | 0.539 | D0C1SF | 0.308 | ||||
ENC003934 | 0.520 | D07MGA | 0.269 | ||||
ENC003715 | 0.483 | D0L1JW | 0.258 | ||||
ENC002425 | 0.461 | D0J4IX | 0.255 | ||||
ENC002592 | 0.454 | D04TDQ | 0.248 | ||||
ENC001570 | 0.452 | D0X5KF | 0.241 | ||||
ENC005418 | 0.440 | D03SKD | 0.236 | ||||
ENC003318 | 0.438 | D01XWG | 0.234 | ||||
ENC005001 | 0.435 | D07VLY | 0.229 | ||||
ENC005002 | 0.433 | D0C9XJ | 0.229 |